Akebia Therapeutics Inc (AKBA)
1.795
-0.06
(-3.49%)
USD |
NASDAQ |
Jan 08, 16:00
1.78
-0.02
(-0.84%)
After-Hours: 20:00
Akebia Therapeutics Shareholders Equity (Quarterly): -50.40M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
Aldeyra Therapeutics Inc | 85.10M |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 207.14M |
Total Liabilities (Quarterly) | 257.54M |
Debt to Equity Ratio | -0.761 |
Current Ratio | 1.524 |
Net Debt Paydown Yield | 0.30% |